NovaBridge Biosciences
NBP
$1.70
-$0.08-4.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 13.21M | 13.21M | 17.24M | 5.81M | 3.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 20.37M | 20.37M | 72.90M | 8.99M | 7.11M |
| Operating Income | -20.37M | -20.37M | -72.90M | -8.99M | -7.11M |
| Income Before Tax | -18.93M | -18.93M | -72.86M | -6.83M | -5.50M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -18.93M | -18.93M | -72.86M | -6.83M | -5.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.93M | -18.93M | -72.86M | -6.83M | -5.50M |
| EBIT | -20.37M | -20.37M | -72.90M | -8.99M | -7.11M |
| EBITDA | -20.34M | -20.34M | -72.89M | -8.97M | -7.10M |
| EPS Basic | -0.38 | -0.38 | -1.45 | -0.15 | -0.16 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.38 | -0.04 | -0.04 |
| EPS Diluted | -0.38 | -0.38 | -1.45 | -0.15 | -0.16 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.38 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 115.72M | 115.72M | 115.55M | 104.21M | 81.70M |
| Average Diluted Shares Outstanding | 50.31M | 50.31M | 50.24M | 45.31M | 35.52M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |